Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine
Authors
Keywords
-
Journal
Proteomics Clinical Applications
Volume 12, Issue 3, Pages 1700135
Publisher
Wiley
Online
2018-02-10
DOI
10.1002/prca.201700135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
- (2017) Vasileios D. Sioulas et al. GYNECOLOGIC ONCOLOGY
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer
- (2016) Farshid Dayyani et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- With or without you — Proteomics with or without major plasma/serum proteins
- (2016) Elisabetta Gianazza et al. Journal of Proteomics
- 2016 update of the PRIDE database and its related tools
- (2016) Juan Antonio Vizcaíno et al. NUCLEIC ACIDS RESEARCH
- Parallel reaction monitoring using quadrupole-Orbitrap mass spectrometer: Principle and applications
- (2016) Adele Bourmaud et al. PROTEOMICS
- Biomarker discovery in mass spectrometry-based urinary proteomics
- (2016) Samuel Thomas et al. Proteomics Clinical Applications
- Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
- (2016) Nuzhat Ahmed et al. Scientific Reports
- SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine
- (2015) George Mermelekas et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates
- (2015) John B. Liao et al. GYNECOLOGIC ONCOLOGY
- Parallel Reaction Monitoring: A Targeted Experiment Performed Using High Resolution and High Mass Accuracy Mass Spectrometry
- (2015) Navin Rauniyar INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recent advances in targeted proteomics for clinical applications
- (2015) Bruno Domon et al. Proteomics Clinical Applications
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Epigenetic regulation of insulin-like growth factor binding protein-3 (IGFBP-3) in cancer
- (2015) Claire M Perks et al. Journal of Cell Communication and Signaling
- Comprehensive Quantitative Analysis of Ovarian and Breast Cancer Tumor Peptidomes
- (2014) Zhe Xu et al. JOURNAL OF PROTEOME RESEARCH
- Characterization and function of human Ly-6/uPAR molecules
- (2013) Hyun Kyung Kong et al. BMB Reports
- Ovarian cancer screening—Current status, future directions
- (2013) Usha Menon et al. GYNECOLOGIC ONCOLOGY
- The utility of isotope-coded protein labeling for prioritization of proteins found in ovarian cancer patient urine
- (2013) Adam Rainczuk et al. JOURNAL OF PROTEOME RESEARCH
- Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis
- (2013) Eliana Bignotti et al. Journal of Translational Medicine
- Western BlotsversusSelected Reaction Monitoring Assays: Time to Turn the Tables?
- (2013) Ruedi Aebersold et al. MOLECULAR & CELLULAR PROTEOMICS
- Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy
- (2012) Kyriaki Ioannou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice
- (2012) Ioannis F. Voutsas et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass
- (2012) Mona Aarenstrup Karlsen et al. GYNECOLOGIC ONCOLOGY
- Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry
- (2012) Michael A Gillette et al. NATURE METHODS
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- Protein biomarkers of ovarian cancer: the forest and the trees
- (2011) Brian M Nolen et al. Future Oncology
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
- (2011) Jürgen Cox et al. JOURNAL OF PROTEOME RESEARCH
- Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies
- (2011) Christoph Krisp et al. Proteomics Clinical Applications
- Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
- (2010) Richard G. Moore et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
- (2010) Brendan MacLean et al. BIOINFORMATICS
- Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms
- (2010) Ingegerd Hellstrom et al. CANCER LETTERS
- Universal sample preparation method for proteome analysis
- (2009) Jacek R Wiśniewski et al. NATURE METHODS
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Urine Biomarkers May Someday Detect Even Distant Tumors
- (2008) C. Schmidt JNCI-Journal of the National Cancer Institute
- Urine in Clinical Proteomics
- (2008) Stéphane Decramer et al. MOLECULAR & CELLULAR PROTEOMICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started